Follow the BioGaia AB stock price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares trade on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, BioGaia AB has recorded 6 public disclosures. Market capitalisation: €11.9bn. The latest transaction was disclosed on 13 August 2025 (Purchase). Among the most active insiders: Theresa Puleo Agnew. All data is accessible without an account.
6
Insider Decl.
n/a
Thresholds
€34,674
4 ops.
Buy Volume
€17m
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate BioGaia AB Strong Buy (bullish), based on 2 analysts. Average price target: SEK 152.50.
35Σ signal
Buys €34,674€17m Sells
Fundamental score
Ranked 6,358 of 28,832 companies
65.6
score / 100
Value
40
Quality
91
FCF yld2.7%
Earn yld2.9%
EV/EBITDA25.3x
ROE31%
Gross mgn73%
Net mgn22%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.